Auston Cherbonneaux: Why Erythritol Just Joined the High-Hazard List
Auston Cherbonneaux, Science Communicator, Author, Publisher, shared a post on LinkedIn about an article by Marco Witkowski, published in Nature Medicine, adding:
“Ingredient Alert
Erythritol (common non caloric sweetener) has evidence to suggest it compromises the blood-brain barrier over time.
This one is a bit more complicated. Still, enough evidence to start taking extreme caution for populations vulnerable to stroke, cardiac events, and thrombosis.
First, a study of about 1000 people suggests that people who are in the upper quartile of erythritol in blood were twice as likely to suffer a major cardiac event compared to the first quartile.
The conclusion to the study referenced in the article [Abstract]:
‘Our findings reveal that erythritol is both associated with incident MACE risk and fosters enhanced thrombosis. Studies assessing the long-term safety of erythritol are warranted.’
Second, experimental finding to this point is only on cells in a petri dish, next step is “blood vessels on a chip” to better mimic physiology.
I don’t need a third.
This is going on the ‘habitual extreme hazard‘ list.”
Title: The artificial sweetener erythritol and cardiovascular event risk
Authors: Marco Witkowski, Ina Nemet, Hassan Alamri, Jennifer Wilcox, Nilaksh Gupta, Nisreen Nimer, Arash Haghikia, Xinmin S. Li, Yuping Wu, Prasenjit rasad Saha, Ilja Demuth, Maximilian König, Elisabeth Steinhagen-Thiessen, Tomas Cajka, Oliver Fiehn, Ulf Landmesser, W. H. Wilson Tang, Stanley L. Hazen

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering